1. Reimer LC, Sardà Carbasse J, Koblitz J, Ebeling C, Podstawka A, Overmann J. BacDive in 2022: the knowledge base for standardized bacterial and archaeal data. Nucleic Acids Res. 2022;
50(D1): D741-D746.
2. Prinzi AM, Moore NM. Change of Plans: Overview of Bacterial Taxonomy, Recent Changes of Medical Importance, and Potential Areas of Impact. Open Forum Infect Dis 2023; 10(7):
ofad269.
3. Procop G, Church D, Hall G, et al. Koneman’s color atlas and textbook of diagnostic microbiology. 7th edition. Wolters Kluwer Health, Philadelphia, PA; 2017: 586-796.
4. Murray PR, Rosenthal KS, Pfaller MA. Medical microbiology. 9th edition. Elsevier Health Sciences; 2020: 257-270.
5. Lofland D, Mahon CR, Lehman DC. Enterobacterales. In: Mahon CR, Lehman DC eds. Textbook of diagnostic microbiology. 7th edition. St. Louis, MO: Elsevier Saunders; 2023: 417-454.
6. Janda JM, Abbott SL. The Changing Face of the Family Enterobacteriaceae (Order: “Enterobacterales”): New Members, Taxonomic Issues, Geographic Expansion, and New Diseases and
Disease Syndromes. Clin Microbiol Rev 2021; 34(2): e00174-20.
7. Töreci K. Enterobacteriaceae Genel Özellikleri. Willke Topcu A, Söyletir G, Doğanay M eds. İnfeksiyon Hastalıkları ve Mikrobiyolojisi. İstanbul: Nobel Tıp Kitabevleri; 2002: 1555-1564.
8. Farmer JJ, III, Farmer MK, Holmes B. The Enterobacteriaceae: general characters, In Borriello SP, Murray PR, Funke G eds. Topley & Wilson’s Microbiology and Microbial Infections. 10th
edition. Hodder Arnold, London, United Kingdom; 2005: 1317–1359.
9. Mahlen SD. Serratia infections: from military experiments to current practice. Clin Microbiol Rev 2011; 24(4): 755-91.
10. Adeolu M, Alnajar S, Naushad S, S Gupta R. Genome-based phylogeny and taxonomy of the ‘Enterobacteriales’: proposal for Enterobacterales ord. nov. divided into the families Enterobacte-
riaceae, Erwiniaceae fam. nov., Pectobacteriaceae fam. nov., Yersiniaceae fam. nov., Hafniaceae fam. nov., Morganellaceae fam. nov., and Budviciaceae fam. nov. Int J Syst Evol Microbiol 2016;
66(12): 5575-5599.
11. Nelson GE, Greene MH. Enterobacteriaceae. In: Bennett JE, Dolin R, Blaser MJ, eds. Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases. 9th ed. Elsevier Health
Sciences; 2020: 2669-2685.
12. De la Maza LM, Pezzlo MT, Bittencourt CE, Peterson EM. Color Atlas of Medical Bacteriology. 3rd edition. Washington, DC: ASM Press; 2020: 91-102.
13. Parte AC, Sardà Carbasse J, Meier-Kolthoff JP, Reimer LC, Göker M. List of Prokaryotic names with Standing in Nomenclature (LPSN) moves to the DSMZ. Int J Syst Evol Microbiol 2020;
70(11): 5607-5612.
14. Schoch CL, Ciufo S, Domrachev M, et al. NCBI Taxonomy: a comprehensive update on curation, resources and tools. Database (Oxford). 2020; 2020:baaa062.
15. Özinel MA. Enterobacteriaceae. Willke Topcu A, Söyletir G, Doğanay M eds. İnfeksiyon Hastalıkları ve Mikrobiyolojisi. İstanbul: Nobel Tıp Kitabevleri; 2017: 1852-1861.
16. Merino S, Aquilini E, Fulton KM, Twine SM, Tomás JM. The polar and lateral flagella from Plesiomonas shigelloides are glycosylated with legionaminic acid. Front Microbiol 2015; 6: 649.
17. Cho GS, Stein M, Brinks E, et al. Serratia nevei sp. nov. and Serratia bockelmannii sp. nov., isolated from fresh produce in Germany and reclassification of Serratia marcescens subsp. sakuensis
Ajithkumar et al. 2003 as a later heterotypic synonym of Serratia marcescens subsp. marcescens. Syst Appl Microbiol 2020; 43(2): 126055.
18. Rai AK, Mitchell AM. Enterobacterial Common Antigen: Synthesis and Function of an Enigmatic Molecule. mBio. 2020; 11(4): e01914-20.
19. Mathers AJ. Enterobacterales: non-enteric infections and multidrug resistance. In: Goldman L, Cooney KA, eds. Goldman- Cecil Medicine. 26th edition. Elsevier Science Health Science; 2023:
1964-1967.
20. Tille PM. Bailey & Scott’s Diagnostic Microbiology. 15th ed. St. Louis Missouri Elsevier; 2022: 335–361.
21. Ma J, Song X, Li M, et al. Global spread of carbapenem-resistant Enterobacteriaceae: Epidemiological features, resistance mechanisms, detection and therapy. Microbiol Res 2023; 266: 127249.
22. Binsker U, Käsbohrer A, Hammerl JA. Global colistin use: a review of the emergence of resistant Enterobacterales and the impact on their genetic basis. FEMS Microbiol Rev 2022; 46(1):
fuab049.
23. Kurekci C, Aydin M, Nalbantoglu OU, Gundogdu A. First report of Escherichia coli carrying the mobile colistin resistance gene mcr-1 in Turkey. J Glob Antimicrob Resist 2018; 15: 169-170.
24. Arabacı Ç, Dal T, Başyiğit T, Genişel N, Durmaz R. Investigation of carbapenemase and mcr-1 genes in carbapenem-resistant Klebsiella pneumoniae isolates. J Infect Dev Ctries 2019; 13(6):
504-509.
25. Jenkins C, Rentenaar RJ, Landraud L, Brisse S. Enterobacteriacea. In: Cohen J, Powderly WG, Opal SM, eds. Infectious Diseases. 4th edition. Elsevier; 2017: 1565–1578.
26. Wojewoda CM, Stempak LM. Medical bacteriology. In: McPherson RA, Pincus MR eds. Henry’s Clinical Diagnosis and Management by Laboratory Methods. 24th edition. Elsevier Health
Sciences; 2022: 1144-1146.
27. Azam MW, Zarrilli R, Khan AU. Updates on the Virulence Factors Produced by Multidrug-Resistant Enterobacterales and Strategies to Control Their Infections. Microorganisms 2023; 11(8):
1901.
28. Noster J, Thelen P, Hamprecht A. Detection of Multidrug-Resistant Enterobacterales-From ESBLs to Carbapenemases. Antibiotics (Basel) 2021; 10(9): 1140.
29. Güran M. Karbapenemaz enzimleri: Türkiye’deki durum üzerine bir derleme/carbapenemase enzymes: A review on situation at Turkey. Türkiye Klinikleri J Med Sci 2016; 36(2): 98-105.
30. Çakar A, Akyön Y, Gür D, et al. Türkiye’de 2014 yılı içinde izole edilen karbapeneme dirençli Escherichia coli ve Klebsiella pneumoniae izolatlarında karbapenemaz varlığının araştırılması[Investigation of carbapenemases in carbapenem-resistant Escherichia coli and Klebsiella pneumoniae strains isolated in 2014 in Turkey]. Mikrobiyol Bul 2016; 50(1): 21-33.
31. Gastrointestinal Sistem Örnekleri Rehberi. KLİMUD Kaynak No: 12, Ankara, 2017. Erişim tarihi:17.12.2023.https://www.klimud.org/uploads/content/Gastrointestinal%20Sistem%20örnek-
leri.pdf
32. Cantón R, Ruiz-Garbajosa P. Treatment guidelines for multidrug-resistant Gram-negative microorganisms. Rev Esp Quimioter 2023; 36 Suppl 1: 46-51.
33. Tamma PD, Aitken SL, Bonomo RA, Mathers AJ, van Duin D, Clancy CJ. Infectious Diseases Society of America 2022 Guidance on the Treatment of Extended-Spectrum β-lactamase Produ-
cing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa). Clin Infect Dis. 2022;
75(2): 187-212.
34. Paul M, Carrara E, Retamar P et al. European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant
Gram-negative bacilli (endorsed by European society of intensive care medicine). Clin Microbiol Infect 2022; 28(4): 521-547.
35. Olney KB, Thomas JK, Johnson WM. Review of novel β-lactams and β-lactam/β-lactamase inhibitor combinations with implications for pediatric use. Pharmacotherapy. 2023; 43(7): 713-731.
36. Kortepeter MG, Cieslak TJ. Bioterrorism. In: Goldman L, Cooney KA, eds. Goldman- Cecil Medicine. 26th edition. Elsevier Science Health Science; 2023: 99.
37. Kroger AT. Orenstein WA. İmmunization. In: Goldman L, Cooney KA, eds. Goldman- Cecil Medicine. 26th edition. Elsevier Science Health Science; 2023: 74.
38. Eren E. Hastanelerde Karbapeneme Dirençli Gram Negatif Bakteri Enfeksiyonlarının Kontrolü. JAMER. 2020; 5(3): 35-8